| Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis E Tacconelli, E Carrara, A Savoldi, S Harbarth, M Mendelson, DL Monnet, ... The Lancet Infectious Diseases 18 (3), 318-327, 2018 | 5132 | 2018 |
| The global threat of antimicrobial resistance: science for intervention I Roca, M Akova, F Baquero, J Carlet, M Cavaleri, S Coenen, J Cohen, ... New microbes and new infections 6, 22-29, 2015 | 1295 | 2015 |
| ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug‐resistant Gram‐negative bacteria in hospitalized patients E Tacconelli, MA Cataldo, SJ Dancer, G De Angelis, M Falcone, U Frank, ... Clinical Microbiology and Infection 20, 1-55, 2014 | 878* | 2014 |
| Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae J Rodríguez-Baño, B Gutiérrez-Gutiérrez, I Machuca, A Pascual Clinical microbiology reviews 31 (2), 10.1128/cmr. 00079-17, 2018 | 733 | 2018 |
| Epidemiology and Clinical Features of Infections Caused by Extended-Spectrum Beta-Lactamase-Producing Escherichia coli in Nonhospitalized Patients J Rodríguez-Bano, MD Navarro, L Romero, L Martínez-Martínez, ... Journal of clinical microbiology 42 (3), 1089-1094, 2004 | 706 | 2004 |
| A Multinational Survey of Risk Factors for Infection with Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Nonhospitalized Patients R Ben-Ami, J Rodríguez-Baño, H Arslan, JDD Pitout, C Quentin, ES Calbo, ... Clinical Infectious Diseases 49 (5), 682-690, 2009 | 681 | 2009 |
| Global dissemination of a multidrug resistant Escherichia coli clone NK Petty, NL Ben Zakour, M Stanton-Cook, E Skippington, M Totsika, ... Proceedings of the National Academy of Sciences 111 (15), 5694-5699, 2014 | 616 | 2014 |
| Community infections caused by extended-spectrum β-lactamase–producing Escherichia coli J Rodríguez-Baño, JC Alcalá, JM Cisneros, F Grill, A Oliver, JP Horcajada, ... Archives of internal medicine 168 (17), 1897-1902, 2008 | 566 | 2008 |
| Nosocomial bacteremia due to Acinetobacter baumannii: epidemiology, clinical features and treatment JM Cisneros, J Rodríguez-Baño Clinical Microbiology and Infection 8 (11), 687-693, 2002 | 531 | 2002 |
| Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective … B Gutiérrez-Gutiérrez, E Salamanca, M de Cueto, PR Hsueh, P Viale, ... The Lancet Infectious Diseases 17 (7), 726-734, 2017 | 488 | 2017 |
| β-Lactam/β-Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum β-Lactamase–Producing Escherichia coli: A Post Hoc … J Rodríguez-Baño, MD Navarro, P Retamar, E Picón, Á Pascual, ... Clinical Infectious Diseases 54 (2), 167-174, 2012 | 465* | 2012 |
| Community-Onset Bacteremia Due to Extended-Spectrum β-Lactamase-Producing Escherichia coli: Risk Factors and Prognosis J Rodríguez-Baño, E Picón, P Gijón, JR Hernández, M Ruíz, C Peña, ... Clinical infectious diseases 50 (1), 40-48, 2010 | 464 | 2010 |
| European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli … M Paul, E Carrara, P Retamar, T Tängdén, R Bitterman, RA Bonomo, ... Clinical Microbiology and Infection 28 (4), 521-547, 2022 | 459 | 2022 |
| Escherichia coli: an old friend with new tidings J Vila, E Sáez-López, JR Johnson, U Römling, U Dobrindt, R Cantón, ... FEMS microbiology reviews 40 (4), 437-463, 2016 | 407 | 2016 |
| Bacteremia Due to Extended-Spectrum β-Lactamase–Producing Escherichia coli in the CTX-M Era: A New Clinical Challenge J Rodríguez-Baño, MD Navarro, L Romero, MA Muniain, M Cueto, ... Clinical infectious diseases 43 (11), 1407-1414, 2006 | 389 | 2006 |
| Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain J Berenguer, P Ryan, J Rodríguez-Baño, I Jarrín, J Carratalà, J Pachón, ... Clinical Microbiology and Infection 26 (11), 1525-1536, 2020 | 360 | 2020 |
| Biofilm formation in Acinetobacter baumannii: associated features and clinical implications J Rodríguez‐Baño, S Marti, S Soto, F Fernández‐Cuenca, JM Cisneros, ... Clinical microbiology and infection 14 (3), 276-278, 2008 | 349 | 2008 |
| Programas de optimización de uso de antimicrobianos (PROA) en hospitales españoles: documento de consenso GEIH-SEIMC, SEFH y SEMPSPH J Rodríguez-Baño, JR Paño-Pardo, L Alvarez-Rocha, Á Asensio, E Calbo, ... Enfermedades Infecciosas y Microbiología Clínica 30 (1), 22. e1-22. e23, 2012 | 326 | 2012 |
| Surveillance for control of antimicrobial resistance E Tacconelli, F Sifakis, S Harbarth, R Schrijver, M van Mourik, A Voss, ... The Lancet Infectious Diseases 18 (3), e99-e106, 2018 | 321 | 2018 |
| Staphylococcus aureus bloodstream infection: a pooled analysis of five prospective, observational studies AJ Kaasch, G Barlow, JD Edgeworth, VG Fowler Jr, M Hellmich, ... Journal of Infection 68 (3), 242-251, 2014 | 305 | 2014 |
